Search Results - "Secci, R"

Differences and Effects of Metabolic Fate of Individual Amino Acid Loss in High-Efficiency Hemodialysis and Hemodiafiltration by Murtas, Stefano, Aquilani, Roberto, Iadarola, Paolo, Deiana, M.L., Secci, R., Cadeddu, M., Bolasco, Piergiorgio

“…The objective of the study was to quantify the loss and arterial blood concentration of the three main classes of amino acids (AAs)—nonessential amino acids…”
Get full text

Morbid obesity in a young woman affected by advanced chronic kidney disease: an exceptional case report. Does a high dose of essential amino acids play a key role in therapeutic success? by Caria, S, Murtas, S, Loria, G, Dioguardi, F S, Secci, R, Bolasco, P

“…A 38-year-old woman, obese (219 kg), diabetic, hypertensive, chronic kidney disease (CKD) stage 4, with low plasma albumin level (2.9 g dl −1 ) and marked…”
Get full text

A polycarbonate RFID tag for blood chain tracking by Fanti, A., Secci, R., Boi, G., Casu, S., Casula, G. A., Mazzarella, G., Montisci, G.

“…In this paper we describe the design of a RFID tag in the UHF band, to be applied to the bags for the collection and transport of blood. RFID use allows to…”
Get full text

AR-V7 in peripheral whole blood of castration-resistant prostate cancer patients: Association with treatment-specific outcome under abiraterone and enzalutamide by Seitz, A.-K., Thoene, S., Bietenbeck, A., Nawroth, R., Tauber, R., Thalgott, M., Schmid, S., Secci, R., Retz, M., Gschwend, J., Ruland, J., Winter, C., Heck, M.

Get full text

609 - AR-V7 in peripheral whole blood of castration-resistant prostate cancer patients: Association with treatment-specific outcome under abiraterone and enzalutamide by Seitz, A.-K., Thoene, S., Bietenbeck, A., Nawroth, R., Tauber, R., Thalgott, M., Schmid, S., Secci, R., Retz, M., Gschwend, J., Ruland, J., Winter, C., Heck, M.

Get full text